Skip to search formSkip to main contentSkip to account menu

proclavaminic acid

Known as: D-threo-Pentonic acid, 5-amino-2,4,5-trideoxy-2-(2-oxo-1-azetidinyl)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Arginase is a binuclear manganese metalloenzyme that serves as a therapeutic target for the treatment of asthma, erectile… 
2006
2006
(3R,5R)-Clavulanic acid, a clinically used inhibitor of serine β-lactamases, is produced by fermentation of Streptomyces… 
Review
2004
Review
2004
The biosynthesis of clavulanic acid and related clavam metabolites is only now being elucidated. Understanding of this pathway… 
2002
2002
During biosynthesis of the clinically used beta-lactamase inhibitor clavulanic acid, one of the three steps catalysed by… 
Highly Cited
2001
Highly Cited
2001
Using a single ferrous active site, clavaminate synthase 2 (CS2) activates O(2) and catalyzes the hydroxylation of… 
1995
1995
Clavaminate synthase (CS), a key enzyme in the clavulanic acid biosynthetic pathway, has been purified to electrophoretic… 
Highly Cited
1990
Highly Cited
1990
A pivotal step in the biosynthetic pathway to the beta-lactamase inhibitor clavulanic acid is the conversion of proclavaminic…